These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16788754

  • 1. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
    Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM.
    Ann Surg Oncol; 2006 Jul; 13(7):933-9. PubMed ID: 16788754
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.
    Lu J, Zhou L, Yang G, Liang ZY, Zhou WX, You L, Yuan D, Li BQ, Guo JC, Zhao YP.
    Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
    Liu J, Cheng Sun SH, Sun SJ, Huang C, Hu HH, Jin YB, Qiu ZJ.
    Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
    [Abstract] [Full Text] [Related]

  • 8. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.
    Clin Cancer Res; 2008 Nov 01; 14(21):7043-9. PubMed ID: 18981001
    [Abstract] [Full Text] [Related]

  • 9. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
    Hollander LL, Guo X, Salem RR, Cha CH.
    J Surg Res; 2015 Aug 01; 197(2):219-24. PubMed ID: 25982376
    [Abstract] [Full Text] [Related]

  • 10. The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.
    Guo M, Luo G, Liu C, Cheng H, Lu Y, Jin K, Liu Z, Long J, Liu L, Xu J, Huang D, Ni Q, Yu X.
    Int J Mol Sci; 2016 Jul 08; 17(7):. PubMed ID: 27399694
    [Abstract] [Full Text] [Related]

  • 11. Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients.
    Park JY, King J, Reber H, Joe Hines O, Mederos MA, Wang HL, Dawson D, Wainberg Z, Donahue T, Girgis M.
    J Surg Oncol; 2021 Feb 08; 123(2):389-398. PubMed ID: 33146409
    [Abstract] [Full Text] [Related]

  • 12. Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival.
    Noi M, Mukaisho KI, Murakami S, Koshinuma S, Machida Y, Yamori M, Nakayama T, Ogawa T, Nakata Y, Shimizu T, Yamamoto G, Sugihara H.
    Clin Exp Dent Res; 2020 Aug 08; 6(4):420-427. PubMed ID: 32281236
    [Abstract] [Full Text] [Related]

  • 13. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining.
    Yamaki S, Yanagimoto H, Tsuta K, Ryota H, Kon M.
    Int J Clin Oncol; 2017 Aug 08; 22(4):726-733. PubMed ID: 28314962
    [Abstract] [Full Text] [Related]

  • 14. Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.
    Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C.
    Am J Clin Oncol; 2008 Aug 08; 31(4):329-34. PubMed ID: 18845990
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Shiihara M, Yamamoto M.
    Scand J Gastroenterol; 2019 Jun 08; 54(6):780-786. PubMed ID: 31180790
    [Abstract] [Full Text] [Related]

  • 16. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
    Osipov A, Nissen N, Rutgers J, Dhall D, Naziri J, Chopra S, Li Q, Hendifar AE, Tuli R.
    Ann Surg Oncol; 2017 Nov 08; 24(12):3674-3682. PubMed ID: 28871564
    [Abstract] [Full Text] [Related]

  • 17. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D, Spizzo G, Mitterer M, Seeber A, Steurer M, Gastl G, Brosch I, Moser P.
    Ann Surg Oncol; 2012 Dec 08; 19(13):4330-6. PubMed ID: 22549289
    [Abstract] [Full Text] [Related]

  • 18. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA, Greenleaf EK, Hollenbeak CS, Wong J.
    Cancer; 2016 Oct 08; 122(19):2979-87. PubMed ID: 27328270
    [Abstract] [Full Text] [Related]

  • 19. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.
    Gut; 2002 Nov 08; 51(5):717-22. PubMed ID: 12377813
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N, Murakami Y, Uemura K, Nakagawa N, Takahashi S, Ohge H, Sueda T.
    Pancreatology; 2017 Nov 08; 17(1):95-102. PubMed ID: 27746094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.